Markus G Seidel

Has grant

Professor of Translational Pediatric Hematology and Immunology

Medical University of Graz

Austria

Research Interests

Explore related searches

Professors in Austria Professors in Immunology Immunology professors in Austria

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Professor Markus G. Seidel is a faculty member at the Medical University of Graz, Austria. His research primarily focuses on translational pediatric hematology and immunology, with recent articles covering topics such as the clinical efficacy of new treatments in patients with immunodeficiencies and the implications of immune dysregulation prior to hematopoietic stem cell transplantation. He is actively involved in advancing precision medicine approaches in the monitoring and treatment of various immunological conditions.

Recent Grants

Grant: Close

Best experimental research award

Open Date: 2016-09-01

Close Date: 2016-09-01

Grant: Close

Professorship Translational Pediatric Hematology and Immunology

Open Date: 2016-01-01

Close Date: 2021-01-01

Grant: Close

Research project grants

Open Date: 2012-01-01

Close Date:

Grant: Close

Jubiläumsfonds (Jubilee fund)

Open Date: 2004-01-01

Close Date: 2005-01-01

Grant: Close

Max Kade Foundation

Open Date: 2000-01-01

Close Date: 2001-01-01

Articles (20)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (21)

Fabio Candotti

Full Professor of Medicine

Lausanne University Hospital

SWITZERLAND

Markus G Seidel

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (20)

Comparative efficacy of leniolisib (CDZ173) versus standard of care on rates of respiratory tract infection and serum immunoglobulin M (IgM) levels among individuals with activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome (APDS): An externally controlled study

Correction to: Pre-Transplant Immune Dysregulation Predicts for Poor Outcome Following Allogeneic Haematopoietic Stem Cell Transplantation in Adolescents and Adults with Inborn Errors of Immunity (IEI) (Journal of Clinical Immunology, (2025), 45, 1, (64), 10.1007/s10875-024-01854-y)

Extended clinical phenotypes and treatment modalities in 32 JAGN1-deficient patients: a multicenter study by ESID and EBMT IEWP

New Insights from Long-Term Clinical Use of Circulating Tumor DNA-Based Minimal Residual Disease Monitoring in Translocation-Associated Sarcomas

Pre-Transplant Immune Dysregulation Predicts for Poor Outcome Following Allogeneic Haematopoietic Stem Cell Transplantation in Adolescents and Adults with Inborn Errors of Immunity (IEI)

Precision medicine in diagnosis, prognosis, and disease monitoring of bone and soft tissue sarcomas using liquid biopsy: a systematic review

Clinical efficacy of SARS‐CoV‐2 Omicron‐neutralizing antibodies in immunoglobulin preparations for the treatment of agammaglobulinemia in patients with primary antibody deficiency

Recommendations for Transitioning Young People with Primary Immunodeficiency Disorders and Autoinflammatory Diseases to Adult Care.

Clinical and Treatment History of Patients with Partial DiGeorge Syndrome and Autoimmune Cytopenia at Multiple Centers

Correction to: Clinical and Treatment History of Patients with Partial DiGeorge Syndrome and Autoimmune Cytopenia at Multiple Centers (Journal of Clinical Immunology, (2024), 44, 2, (42), 10.1007/s10875-023-01607-3)

Concurrence of a kinase-dead BRAF and an oncogenic KRAS gain-of-function mutation in juvenile xanthogranuloma.

Correction to: The Immune Deficiency and Dysregulation Activity (IDDA2.1 ‘Kaleidoscope’) Score and Other Clinical Measures in Inborn Errors of Immunity

The Immune Deficiency and Dysregulation Activity (IDDA2.1 ‘Kaleidoscope’) Score and Other Clinical Measures in Inborn Errors of Immunity

Simple Measurement of IgA Predicts Immunity and Mortality in Ataxia-Telangiectasia.

Therapeutic options for CTLA-4 insufficiency.

Curation and expansion of Human Phenotype Ontology for defined groups of inborn errors of immunity.

Different Apples, Same Tree: Visualizing Current Biological and Clinical Insights into CTLA-4 Insufficiency and LRBA and DEF6 Deficiencies.

Initial presenting manifestations in 16,486 patients with inborn errors of immunity include infections and noninfectious manifestations.

Misdiagnosed thrombocytopenia in children and adolescents: analysis of the Pediatric and Adult Registry on Chronic ITP

A distinct CD38+CD45RA+ population of CD4+, CD8+, and double-negative T cells is controlled by FAS.

Collaborators (21)

Fabio Candotti

Ann Gardulf

Robbert Bredius

Stephan Ehl

Luis Ignacio Gonzalez-Granado

Nikolaus Rieber

Bertram Bengsch

Tracy Briggs

Raphael Johannes Scheible

Judith Sánchez-Manubens

Armin Zebisch

Michiel van der Flier

Geraldine Blanchard-Rohner

Luka Brcic

Thomas Kühne

Esther de Vries

Marta Rizzi

Janine Reichenbach

Sofia Nyström

Antonios Kolios

Jiří Litzman

Make your next move.